As it promised last month, Bayer, the world's largest seed and agricultural chemicals company, asked the U.S. Supreme Court on Monday to overturn the $25-million award to Edwin Hardeman, a California man who blamed Roundup herbicide for giving him cancer. The appeal is a key element in Bayer's plan to resolve billions of dollars of claims against Roundup and its active ingredient, glyphosate, the most widely used weedkiller in the world.
Health and chemical giant Bayer said it would pursue a five-point plan to mitigate its future litigation risks over Roundup herbicide, including a discussion of whether to remain in the lawn-and-garden market and a continued pursuit of settlements of lawsuits that allege the weedkiller causes cancer.
In its second proposal to settle future lawsuits that allege its Roundup weedkiller is carcinogenic, seed and ag-chemical giant Bayer said on Wednesday that it would pay up to $200 million to individual claimants and a maximum of $2 billion overall to cover lawsuits filed in the next four years.
Two weeks after agreeing to pay up to $9.6 billion to resolve thousands of cancer lawsuits against glyphosate, seed and ag-chemical giant Bayer is still looking for a way to handle future litigation against the weedkiller. A proposal to appoint a panel of experts to decide if glyphosate is carcinogenic — a pivotal question for cases filed in coming years — died on Wednesday following criticism from the federal judge handling the lawsuits.
Under the terms of an agreement announced Wednesday, seed and agribusiness giant Bayer will pay up to $10.9 billion to resolve lawsuits that accuse its Roundup herbicide of causing cancer, and an additional $400 million to settle litigation claiming crop damage caused by its dicamba weedkiller from 2015 to 2020.
Glyphosate, the most widely used herbicide in the world, poses no threat to human health when used as directed and is unlikely to cause cancer, said the EPA in an interim decision on Thursday. Environmental groups denounced the decision as faulty.
Chiding California regulators for "misleading labeling requirements," the EPA told herbicide makers to remove cancer warnings from containers of glyphosate, the most widely used weedkiller in the world, in a step that would benefit seed and ag chemical giant Bayer. Meanwhile, a court-appointed mediator dismissed as "pure fiction" a report that the German company offered $8 billion to settle all U.S. lawsuits against Roundup, Bayer's glyphosate-based herbicide.
The GMO wheat discovered growing wild in a Washington State field this spring actually sprouted from two different strains developed by Monsanto, the USDA announced over the weekend. Genetically engineered wheat is not approved for cultivation anywhere in the world, yet "volunteer" herbicide-resistant plants have been confirmed four times in the U.S. Northwest more than a decade after field trials ended.
The USDA has never approved cultivation of genetically engineered wheat, yet for the fourth time since April 2013 a wheat strain resistant to the weedkiller glyphosate was found growing wild in the northwestern United States. The discovery could disrupt wheat exports and it raises questions about USDA's ability to police agricultural biotechnology.
In a bellwether trial, a federal jury found Monsanto liable for causing blood cancer in a man who used its Roundup weedkiller, and awarded the man, Edwin Hardeman, more than $80 million in damages, said The Recorder.